Credit Rating

Date: 29th June 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers 5th Floor, Exchange Plaza, Dalal Street Bandra Kurla Complex, Bandra (East) Mumbai – 400 001 Mumbai - 400051 Scrip Code: 540937 Symbol: MEDICO Dear Sir/Madam, Subject: Intimation regarding Credit rating for Company’s Long Term and Short-Term Bank Facilities Under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that CRISIL Ratings Limited has reviewed the rating for the following instruments: Facilities Amount (Rs. crore) Rating Long Term Bank Facilities 19 Crisil BBB-/Stable Short Term Bank Facilities 18 Crisil BBB-/Stable (Fund Based) Short Term Bank Facilities 5 Crisil A3 (Non-fund Based) Total Facilities 42.00 (Rs. Forty-Two Crore Only) The rating letter received from CRISIL Ratings Limited is attached as Annexure. Kindly take the same on records. Thanking You. Yours sincerely, FOR MEDICO REMEDIES LIMITED HARESH MEHTA CHAIRMAN & WHOLE-TIME DIRECTOR DIN: 01080289 Encl: As above CONFIDENTIAL RL/MDCOR/395132/BLR/0626/149647 June 25, 2026 Mr. Harshit Mehta Director Medico Remedies Limited 1105/1106, 11th Floor, Hubtown Solaris Opp. Telli Galli,Andheri East Mumbai City - 400069 9819657276 Dear Mr. Harshit Mehta, Re: Review of Crisil Ratings on the bank facilities of Medico Remedies Limited All ratings assigned by Crisil Ratings are kept under continuous surveillance and review. Please find in the table below the ratings outstanding for the debt instruments/facilities of the company, and the rating actions by Crisil Ratings on the ratings as on date. Total Bank Loan Facilities Rated Rs.42 Crore (Enhanced from Rs.19 Crore) Long Term Rating Crisil BBB-/Stable (Reaffirmed) Short Term Rating Crisil A3 (Reaffirmed) (Bank-wise details as per Annexure 1) As per our Rating Agreement, Crisil Ratings would disseminate the ratings, along with the outlook, through its publications and other media, and keep the ratings, along with the outlook, under surveillance over the life of the instrument/facility. Crisil Ratings reserves the right to withdraw, or revise the ratings, along with the outlook, at any time, on the basis of new information, or unavailability of information, or other circumstances which Crisil Ratings believes may have an impact on the ratings. Please visit www.crisilratings.com and search with the name of the rated entity to access the latest rating/s. In the event of the company not availing the proposed facilities within a period of 180 days from the date of this letter, a fresh letter of revalidation from Crisil Ratings will be necessary. Crisil Ratings products / activities or ratings of instruments other than securities that are listed or proposed to be listed may fall under the purview of financial sector regulators (FSRs) other than SEBI. In respect of such products / activities or ratings (under the purview of other FSRs such as Reserve Bank of India (RBI), Ministry of Corporate Affairs (MCA), Insurance Regulatory and Development Authority of India (IRDAI), among others), the grievance / dispute redressal and investor protection mechanisms available under SEBI regulations shall not be applicable. A list of products/activities or ratings of instruments falling under the purview of various FSRs along with the names of respective FSRs has been duly disclosed by Crisil Ratings on its website. A link to the same has been provided below for ready reference: https://www.crisilratings.com/en/home/our-business/ratings/regulatory-disclosures/list-of-activities-instruments-and-names-of- regulators.html This letter will remain valid till March 31, 2027. After this date, please insist for a new rating letter (dated later than March 31, 2027). Should you require any clarification, please feel free to get in touch with us. warm regards, Yours sincerely, Himank Sharma Nivedita Shibu Director - Crisil Ratings Director - Crisil Ratings Disclaimer: A rating by Crisil Ratings reflects Crisil Ratings’ current opinion on the likelihood of timely payment of the obligations under the rated instrument, and does not constitute an audit of the rated entity by Crisil Ratings. Our ratings are based on information provided by the issuer or obtained by Crisil Ratings from sources it considers reliable. Crisil Ratings does not guarantee the completeness or accuracy of the information on which the rating is based. A rating by Crisil Ratings is not a recommendation to buy / sell or hold the rated instrument; it does not comment on the market price or suitability for a particular investor. Crisil Ratings has a practice of keeping all its ratings under surveillance and ratings are revised as and when circumstances so warrant. Crisil Ratings is not responsible for any errors and especially states that it has no financial liability whatsoever to the subscribers / users / transmitters / distributors of its ratings. Crisil Ratings’ criteria are available without charge to the public on the web site, www.crisilratings.com. Crisil Ratings or its associates may have other commercial transactions with the company/entity. For the latest rating information on any instrument of any company rated by Crisil Ratings, please visit www.crisilratings.com or contact Customer Service Helpdesk at Crisilratingdesk@crisil.com or at 1800-267-3850 Annexure 1 - Bank-wise details of various facility classes (outstanding facilities) Amount (Rs. S.No. Bank Facility Bank Outstanding Rating in Crore) 1 Letter of Credit Kotak Mahindra Bank Limited 5 Crisil A3 2 Packing Credit Kotak Mahindra Bank Limited 4 Crisil BBB-/Stable 3 Packing Credit Kotak Mahindra Bank Limited 14 Crisil BBB-/Stable 4 Term Loan Kotak Mahindra Bank Limited 19 Crisil BBB-/Stable Total 42 Annexure: List of instruments and names of regulators of the instruments As required by SEBI CRA Circular dated Feb 10, 2026, a list of activities or instruments falling under the purview of various FSRs, along with the names of respective FSRs, is being disclosed below: A. Rating activities Sr. No. Instrument / activity Name Regulator of the instruments 1 Listed/Proposed to be listed bonds/debentures/preference share (all securities) SEBI 2 Unlisted/Proposed to be unlisted Bonds/Debentures/ Preference share (all securities) MCA 3 Listed PTCs / Securitisation Notes (originated by entities regulated by RBI)* SEBI 4 Listed PTCs / Securitisation Notes (originated by entities not regulated by RBI)* SEBI 5 Unlisted PTCs / Securitisation Notes (originated by entities regulated by RBI)* RBI 6 Listed Commercial Paper and NCDs with original maturity less than 1 year RBI 7 Unlisted Commercial Paper and NCDs with original maturity less than 1 year RBI 8 Loan Facilities (Fund/Non-Fund Based) from Bank/NBFCs/NHB/FIs ^ RBI 9 External Commercial Borrowings and other similar borrowings RBI 10 Certificates of Deposit RBI 11 Fixed Deposits raised by NBFC's, Banks, HFCs, Fis RBI 12 Fixed Deposits raised by corporates other than NBFCs, Banks, HFCs, FIs MCA 13 Inter Corporate Deposits/Loans extended by Corporates MCA 14 Borrowing programme ~ - 15 Issuer Ratings # - 16 Credit Ratings for Capital Protection Oriented Schemes (by Mutal Funds and AIFs) SEBI 17 Credit quality ratings (CQRs) for Mutual Fund Schemes and Schemes of AIFs SEBI 18 Listed Security Receipts SEBI 19 Unlisted Security Receipts RBI 20 Independent Credit Evaluation (ICE) RBI 21 Expected Loss Ratings (for Loan Facilities (Fund/Non-Fund Based) from RBI Bank/NBFCs/NHB/Fis) 22 Expected Loss Ratings (Listed/Proposed to be listed bonds/debentures/preference SEBI share (all securities)) 23 Expected Loss Ratings (Unlisted/Proposed to be unlisted Bonds/Debentures/ MCA Preference share (all securities)) 24 Unlisted PTCs / Securitisation Notes (originated by entities not regulated by RBI) * Investor-side regulator such as IRDAI, PFRDA * Includes securit [Showing first 8,000 characters — download PDF for full document]